BioSpace News Archive

Drug Development

Sensei Biotherapeutics Announces Clinical Supply Agreement with Regeneron for Phase 1/2 Clinical Trial Evaluating SNS-101

Sensei Biotherapeutics, Inc. today announced a clinical supply agreement with Regeneron for its anti-PD1 therapy Libtayo ® (cemiplimab).

January 5, 2023
·
5 min read
Pharm Country

BrainStorm Cell Therapeutics to Present at Biotech Showcase™ 2023

BrainStorm Cell Therapeutics Inc. today announced that Chaim Lebovits , President and CEO, and Stacy Lindborg, Co-CEO, will jointly present a corporate and clinical overview at 10:30 a.m. PT on Monday, Jan. 9 at Biotech Showcase™ 2023.

January 5, 2023
·
3 min read
Business

Palatin Announces Preliminary Second Quarter Fiscal 2023 Vyleesi® Product Sales Results

Palatin Technologies, Inc. today announced preliminary fiscal second quarter ended December 31, 2022 Vyleesi® product sales results.

January 5, 2023
·
5 min read
Genetown

QurAlis Announces First-in-Human Dose in Phase 1 Clinical Trial of QRL-101, a First-in-Class Kv7 Precision Therapy for ALS

QurAlis Corporation today announced that the company recently initiated dosing in a Phase 1 clinical trial of QRL-101 (QRA-244), a first-in-class selective Kv7.2/7.3 ion channel opener for the treatment of hyperexcitability-induced disease progression in ALS.

January 5, 2023
·
4 min read
Genetown

Black Diamond Therapeutics to Present at the 41st Annual J.P. Morgan Healthcare Conference

Black Diamond Therapeutics, Inc. announced that its President and Chief Executive Officer, David M. Epstein, Ph.D., will present an update on the Company’s progress at the 41st Annual J.P. Morgan Healthcare Conference on Thursday, January 12, 2023, at 9:00 a.m. PT in San Francisco, California.

January 5, 2023
·
1 min read
BioMidwest

WishBone Medical Partners With Clubfoot Solutions to Distribute the Iowa Brace for Pediatric Patients in the U.S.

WishBone Medical, Inc. has entered into a distribution agreement with Clubfoot Solutions, naming WishBone the exclusive pediatric medical device manufacturer to offer the Iowa Brace throughout the United States.

January 5, 2023
·
3 min read
Business

AbbVie to Host Fourth-Quarter 2022 Earnings Conference Call

AbbVie (NYSE: ABBV) will announce its fourth-quarter 2022 financial results on Thursday, February 9, 2023, before the market opens.

January 5, 2023
·
1 min read
Abivax Publishes Novel Data with Respect to Obefazimod’s Anti-Inflammatory Mechanism of Action

Abivax SA announced the publication of a scientific article in the peer-reviewed journal Clinical and Translational Gastroenterology entitled: “ABX464 up-regulates miR-124 to reduce pro-inflammatory markers in inflammatory bowel diseases.” [1]

January 5, 2023
·
8 min read
Policy

Azafaros Receives FDA’s IND Clearance and Fast Track Designation for Lead Asset AZ-3102

Azafaros B.V. announced that it has received Investigational New Drug clearance from the United States Food and Drug Administration to conduct a clinical Phase 2 trial for its lead asset, AZ-3102, for the treatment of GM2 gangliosidosis and Niemann-Pick disease type C.

January 5, 2023
·
5 min read
Business

KalVista Pharmaceuticals Announces Benjamin L. Palleiko Promoted to President

KalVista Pharmaceuticals, Inc. announced the promotion of Ben Palleiko, the Company’s current Chief Business Officer and Chief Financial Officer, to the additional title of President.

January 5, 2023
·
4 min read